Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Clal Biotechnology Industries

Status
ACTIVE
Global HQ
Tel Aviv, Israel
Countries of investment
  • Israel
Investment stages
  • Series B
  • Series C
Industries
  • Biotechnology
  • Health Tech
  • AI
About
CBI Clal Biotechnology Industries is a leading Israeli life sciences investment company empowering science-backed projects to develop breakthrough solutions for serious medical needs.
Min check size
$10M
Max check size
$30M
Fund size
NPS

Investment Thesis

Clal Biotechnology Industries focuses on investing in life sciences and healthcare companies, with a particular emphasis on biotechnology and pharmaceutical innovation.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a strong foundation in technology and healthcare investments, the fund manager has actively engaged in over 30 deals across North America and Europe. Demonstrating a data-driven approach, they focus on early to growth-stage companies, consistently identifying opportunities that align with emerging market trends. Noteworthy exits have included successful IPOs and acquisitions, showcasing their strategic foresight and operational expertise. Their commitment to thematic investing allows for a nuanced understanding of sector dynamics, positioning themselves as a valuable partner for innovative ventures.

Clal Biotechnology Industries Contacts Information

Primary contact

Secondary contact

Team

Ofer Goldberg

Ofer Gonen

Amos Bankirer

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp